Correlation Between Mereo BioPharma and Uniper SE

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Mereo BioPharma and Uniper SE at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mereo BioPharma and Uniper SE into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mereo BioPharma Group and Uniper SE, you can compare the effects of market volatilities on Mereo BioPharma and Uniper SE and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mereo BioPharma with a short position of Uniper SE. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mereo BioPharma and Uniper SE.

Diversification Opportunities for Mereo BioPharma and Uniper SE

0.13
  Correlation Coefficient

Average diversification

The 3 months correlation between Mereo and Uniper is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding Mereo BioPharma Group and Uniper SE in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Uniper SE and Mereo BioPharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mereo BioPharma Group are associated (or correlated) with Uniper SE. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Uniper SE has no effect on the direction of Mereo BioPharma i.e., Mereo BioPharma and Uniper SE go up and down completely randomly.

Pair Corralation between Mereo BioPharma and Uniper SE

Assuming the 90 days trading horizon Mereo BioPharma Group is expected to generate 1.37 times more return on investment than Uniper SE. However, Mereo BioPharma is 1.37 times more volatile than Uniper SE. It trades about 0.02 of its potential returns per unit of risk. Uniper SE is currently generating about -0.04 per unit of risk. If you would invest  357.00  in Mereo BioPharma Group on September 3, 2024 and sell it today you would lose (2.00) from holding Mereo BioPharma Group or give up 0.56% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy99.22%
ValuesDaily Returns

Mereo BioPharma Group  vs.  Uniper SE

 Performance 
       Timeline  
Mereo BioPharma Group 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Mereo BioPharma Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Uniper SE 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Uniper SE are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Uniper SE may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Mereo BioPharma and Uniper SE Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Mereo BioPharma and Uniper SE

The main advantage of trading using opposite Mereo BioPharma and Uniper SE positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mereo BioPharma position performs unexpectedly, Uniper SE can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Uniper SE will offset losses from the drop in Uniper SE's long position.
The idea behind Mereo BioPharma Group and Uniper SE pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Complementary Tools

Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites